| CYSB2200228 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400166 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | Supplementary Application | 2024-07-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CXSS2200007 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2022-01-26 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CYSB2101240 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2021-10-27 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSL2300177 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-03-08 | | Nanjing Han Xin Pharmaceutical Technology Co Ltd | | | view |
| CYSB2101177 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-09-06 | | Gan & Lee Pharmaceuticals | | | view |
| CXSS2101010 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.4) | New Drug Application | 2021-07-13 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400063 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-03-08 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2200235 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-28 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400219 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-08-17 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2200229 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2200289 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-12-27 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2101163 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-08-20 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2300217 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-11-29 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSL2400365 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2024-06-04 | | Ningbo Kunpeng BIOTECH Co Ltd | | | view |
| CYSB2101305 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-12-23 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2400300 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-11-14 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2101313 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2021-09-08 | | ChongQing Chenan Biopharmaceutical Co Ltd | | | view |
| CYSB2300032 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2023-02-09 | | Gan & Lee Pharmaceuticals | | | view |
| JYSB2101210 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-12-23 | | Novo Nordisk A/S | | | view |
